Gevo raises $107 million in its IPO as synbio stays in the spotlight

February 10, 2011 | Analyst Insight

Earlier this week, isobutanol producer Gevo raised $107 million in its initial public offering (IPO). The synthetic biology company sold approximately 7.1 million shares at $15 apiece, with shares trading as...